ESR1 and breast cancer: A multivariate Cox proportional hazards survival analysis revealed that TSTD1 mRNA expression in patients with breast cancer was significantly associated with poor 5-year overall survival in TCGA data (p = 0.021, Table 3), especially in patients with negative ER/PR expression (p = 0.008, Table 3).